Adelaide’s BioMed City is attracting strong clinical trial interest as its critical mass continues to growCameron EnglandThe Australian Business NetworkFri, 14 May 2021 3:32PMPremiumPremiumSubscribers with digital access can view this article.Already a subscriber?Login here.